Home Biosimilar Antibodies Others CD markers antibody Inebilizumab (Anti-CD19) For research use only.
Not for use in humans.

Inebilizumab (Anti-CD19)

Synonyms:

Inebilizumab (Anti-CD19) is an monoclonal antibody targeting CD19 antigen present on B cells. Inebilizumab can be used for multiple sclerosis and neuromyelitis optica research. MW:145.5 KD.

Inebilizumab (Anti-CD19)

Purity & Quality Control

Choose Selective CD markers Inhibitors

Biological Activity

Description Inebilizumab (Anti-CD19) is an monoclonal antibody targeting CD19 antigen present on B cells. Inebilizumab can be used for multiple sclerosis and neuromyelitis optica research. MW:145.5 KD.

Product Details

CAS No. 1299440-37-1
Molecular Weight 147.42 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Inebilizumab (Anti-CD19) | Inebilizumab (Anti-CD19) supplier | purchase Inebilizumab (Anti-CD19) | Inebilizumab (Anti-CD19) cost | Inebilizumab (Anti-CD19) manufacturer | order Inebilizumab (Anti-CD19) | Inebilizumab (Anti-CD19) distributor